ENDOTAK C
Report
- Report Number
- 2124215-2012-17109
- Event Type
- Injury
- Date Received
- January 14, 2013
- Date of Event
- December 18, 2012
- Report Date
- February 22, 2013
- Manufacturer
- CPI PLANT - LEWICKI
- Product Code
- NVY
- PMA / PMN Number
- P910073
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
ACCORDING TO AVAILABLE INFORMATION, THIS LEAD REMAINS IMPLANTED AND IN SERVICE. WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS EVENT WILL BE UPDATED.
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
SUBSEQUENTLY, A REVISION PROCEDURE WAS PERFORMED. THIS LEAD WAS SURGICALLY ABANDONED AND REPLACED. IN ADDITION, THE DEVICE WAS ALSO REPLACED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS RIGHT VENTRICULAR LEAD AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR EXPERIENCED VENTRICULAR TACHYCARDIA (VT) FOR WHICH A SUCCESSFUL SHOCK WAS DELIVERED. POST SHOCK DELIVERY, SHOCK IMPEDANCE MEASUREMENTS HAD DECREASED SINCE IMPLANT TO A LOW OUT OF RANGE MEASUREMENT. AN INTERNAL TECHNICAL SERVICE (TS) CONSULTANT WAS CONTACTED AND PROVIDED WITH A DATA DOWNLOAD TO DETERMINE THE ACTUAL SHOCK LEAD IMPEDANCE VALUE. TS RECOMMENDED MONITORING THIS SYSTEM AS A SHORT COULD OCCUR IF A SHOCK IS DELIVERED. ENGINEERING REVIEWED THE DATA AND PROVIDED THE ACTUAL SHOCK LEAD MEASUREMENT WAS LESS THAN 12.5 OHMS. TS CONCLUDED THERE MAY BE A SHOCK LEAD ISSUE AND RECOMMENDED FURTHER LEAD INTEGRITY TESTING BE PERFORMED. NO ADVERSE PATIENT SYMPTOMS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 20163 | ENDOTAK C | IMPLANTABLE LEAD | NVY | CPI PLANT - LEWICKI | 0070 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Hospitalization| L| R |